| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0300-9084(01)01242-1 |
| P698 | PubMed publication ID | 11295493 |
| P2093 | author name string | Huber R | |
| Köhler A | |||
| Moroder L | |||
| Glickman MH | |||
| Bajorek M | |||
| Finley D | |||
| Groll M | |||
| Rubin DM | |||
| P2860 | cites work | Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis | Q24561722 |
| Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes | Q24673104 | ||
| A gated channel into the proteasome core particle | Q27627907 | ||
| Structural basis for the activation of 20S proteasomes by 11S regulators | Q27628418 | ||
| Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution | Q27730197 | ||
| Structure of 20S proteasome from yeast at 2.4 A resolution | Q27735081 | ||
| Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly | Q27931608 | ||
| Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation | Q27932645 | ||
| A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. | Q27936509 | ||
| Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome | Q27937064 | ||
| In vivo half-life of a protein is a function of its amino-terminal residue | Q28287702 | ||
| The 26S proteasome: a molecular machine designed for controlled proteolysis | Q29619692 | ||
| The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study | Q30779094 | ||
| Proteasomes and other self-compartmentalizing proteases in prokaryotes | Q33542295 | ||
| The proteasome | Q33689946 | ||
| The proteasome, a novel protease regulated by multiple mechanisms | Q33700949 | ||
| Structure and mechanism of ATP-dependent proteases | Q33745046 | ||
| The proteasome activator 11 S REG (PA28) and class I antigen presentation | Q33796158 | ||
| Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants | Q34753108 | ||
| Conformational constraints for protein self-cleavage in the proteasome | Q47923187 | ||
| Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown | Q73075592 | ||
| Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome | Q73778113 | ||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 325-332 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Biochimie | Q2904035 |
| P1476 | title | The substrate translocation channel of the proteasome. | |
| P478 | volume | 83 |
| Q27934511 | A proteasomal ATPase contributes to dislocation of endoplasmic reticulum-associated degradation (ERAD) substrates. |
| Q34299042 | ASK1 negatively regulates the 26 S proteasome |
| Q36673300 | Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions |
| Q35209250 | Archaeal proteasomes: potential in metabolic engineering |
| Q44021101 | Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation |
| Q55401911 | Cationic porphyrins are tunable gatekeepers of the 20S proteasome. |
| Q41107536 | Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study |
| Q37711312 | Effects of ethanol on the proteasome interacting proteins |
| Q47137426 | Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding. |
| Q38355943 | Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit. |
| Q28487088 | Identification of substrates of the Mycobacterium tuberculosis proteasome |
| Q44082373 | Increased degradation of oxidized proteins in yeast defective in 26 S proteasome assembly |
| Q44517886 | Inhibition of proteasome activity by selected amino acids |
| Q93160103 | Intracellular Peptides in Cell Biology and Pharmacology |
| Q81274554 | New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer |
| Q28259006 | Parkin interacts with the proteasome subunit alpha4 |
| Q52913169 | Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome. |
| Q35792807 | Proteasomes and protein conjugation across domains of life |
| Q36597934 | Proteasomes from structure to function: perspectives from Archaea |
| Q34700398 | Protein degradation and the generation of MHC class I-presented peptides. |
| Q92063917 | Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress |
| Q47916219 | Rapid degradation of solid-phase bound peptides by the 20S proteasome |
| Q37396451 | Structural insights into proteasome activation by the 19S regulatory particle |
| Q42114358 | Structure of the human 26S proteasome: subunit radial displacements open the gate into the proteolytic core |
| Q33958918 | Taking a bite: proteasomal protein processing |
| Q45258108 | The ClpP double ring tetradecameric protease exhibits plastic ring-ring interactions, and the N termini of its subunits form flexible loops that are essential for ClpXP and ClpAP complex formation |
| Q41877787 | The Not4 E3 ligase and CCR4 deadenylase play distinct roles in protein quality control |
| Q35226259 | The asymmetry in the mature amino-terminus of ClpP facilitates a local symmetry match in ClpAP and ClpXP complexes |
| Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
| Q26749321 | The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease |
| Q35836872 | The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention |
Search more.